Global Microarray Market

Report Highlights

The global market for microarrays is estimated to grow from $4.0 billion in 2022 to $5.7 billion in 2027, with a compound annual growth rate (CAGR) of 7.6% for the period of 2022-2027.

Report Includes

• 76 total tables
• A comprehensive overview and up-to-date analysis of the global microarray market
• Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and future market potential for global microarray industry, and areas of focus to forecast this market into various segments and sub-segments
• Estimation of the actual market size and revenue forecast for microarrays in USD million values, and corresponding market share analysis by product type, application and geographic region
• In-depth information on the major market drivers and opportunities, industry shifts and regulations, and other demographic factors that will influence this market demand in the coming years (2022-2027)
• Insight into the major technology updates, issues and risks, government regulations, breakthrough innovations, collaborations and developments, and costs and benefits of microarrays in the genomics industry
• Holistic review of the COVID-19 pandemic impact on microarray technologies market
• Updated information on the technology landscape of microarrays market, novel products launch, new and emerging applications in the life sciences, and ongoing clinical trials etc.
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• Descriptive company profiles of the market leading players, including Geron, Epic Sciences Inc., Genexine, Commence Bio and Vitatex Inc.

Report Scope

This report incorporates an in-depth analysis of the microarray market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for medical device technologies.

The scope of the report is limited to only those microarray markets that generate the most global revenue. Genomics and proteomics and the NGS market are already covered in other BCC Research reports, so these have been excluded.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World region. For market estimates, data is provided for the base year 2021, and forecast through 2027.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.